Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

This study has been completed.
Sponsor:
Collaborators:
Moulins Hospital
Centre Hospitalier Universitaire de Saint Etienne
LA ROCHE SUR YON HOSPITAL
Information provided by:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT00336687
First received: June 13, 2006
Last updated: March 26, 2010
Last verified: March 2010
  Purpose

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.


Condition
Thrombopenia

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

Further study details as provided by University Hospital, Clermont-Ferrand:

Primary Outcome Measures:
  • Epidemiology of Thrombopenia and its consequences. [ Time Frame: in reanimation ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • The impact of cost and mortality of Thrombopenia in reanimation. [ Time Frame: in reanimation ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 322
Study Start Date: July 2005
Study Completion Date: November 2006
Detailed Description:

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients of Reanimation

Criteria

Inclusion Criteria:

  • Thrombopenia in reanimation

Exclusion Criteria:

  • Pregnancy
  • Contraindication of myelogram
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00336687

Locations
France
Clermont-Ferrand University Hospital
Clermont-Ferrand, Auvergne, France, 63000
Sponsors and Collaborators
University Hospital, Clermont-Ferrand
Moulins Hospital
Centre Hospitalier Universitaire de Saint Etienne
LA ROCHE SUR YON HOSPITAL
Investigators
Study Director: Fabrice Thiolliere, Dr University Hospital, Clermont-Ferrand
  More Information

No publications provided

Responsible Party: Fabrice Thiollière, CHU Clermont-Ferrand
ClinicalTrials.gov Identifier: NCT00336687     History of Changes
Other Study ID Numbers: CHU63-0013
Study First Received: June 13, 2006
Last Updated: March 26, 2010
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Clermont-Ferrand:
Thrombopenia
Reanimation
Thrombopenia in reanimation

Additional relevant MeSH terms:
Thrombocytopenia
Blood Platelet Disorders
Hematologic Diseases

ClinicalTrials.gov processed this record on July 20, 2014